Pancreatic Cancer Research

ResearcherNagoya City UniversityNo recent work listed

Tomoya Shamoto

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5000176667. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper

Papers 3

  1. Xanthohumol inhibits angiogenesis by suppressing nuclear factor-κB activation in pancreatic cancer. Co-author DOI 10.1111/cas.13441↗
  2. Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists. Co-author DOI 10.1186/s12885-016-2340-z↗
  3. Zerumbone inhibits angiogenesis by blocking NF-κB activity in pancreatic cancer. Co-author DOI 10.1097/mpa.0000000000000039↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yoichi Matsuo · 3 shared papers, 2014–2018 · strength 0.18
  2. Hiroki Takahashi · 3 shared papers, 2014–2018 · strength 0.18
  3. Mamoru Morimoto · 2 shared papers, 2016–2018 · strength 0.13
  4. Kenta Saito · 2 shared papers, 2016–2018 · strength 0.13
  5. Hiromitsu Takeyama · 2 shared papers, 2014–2016 · strength 0.10
  6. Hiroyuki Imafuji · 1 shared paper, 2018 · strength 0.07
  7. Shuji Takiguchi · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.